- 询价
- R&D Systems
- 1299-NK-050
- 美国
- 2025年07月15日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商：
国外
- 库存：
大量
- 英文名：
Recombinant Human NKG2D/Fc Chimera, CF
- 规格：
50µg
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Design of Gene Therapy Clinical Trials in CF Patients
On April 17, 1993, Crystal and co-workers initiated the first human gene therapy trial for cystic fibrosis (CF). In that study, a replication-deficient recombinant adenovirus encoding cystic fibrosis transmembrane conductance regulator (CFTR
Recombinant Antigens in Viral Diagnosis
(CF) assays (2 ). Although these assays can be specific and reliable in the hands of an experienced laboratory worker, they suffer from several significant disadvantages. HI and CF assays are frequently very specific, but are relatively insensitive
cells. We present here (i) a detailed protocol for the production and purification of soluble recombinant NK cell receptors tagged with human IgG1-Fc (thus termed receptor-Fc chimera or receptor-Ig fusion protein) and (ii) a protocol for cell staining
技术资料暂无技术资料 索取技术资料
